Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
KP-201 by Korea Pharma for Gastric Ulcers: Likelihood of Approval
KP-201 is under clinical development by Korea Pharma and currently in Phase I for Gastric Ulcers. According to GlobalData, Phase...